H Shirin, J M Schapiro, N Arber, J Pinkhas, Y Sidi, F Salomon
Index: Ann. Pharmacother. 26(12) , 1522-3, (1992)
Full Text: HTML
To report a case of erythromycin base-induced rash and liver function disturbances.A patient with erythema nodosum and high antistreptolysin-O titers was treated with erythromycin on the assumption that occult streptococcal infection was the cause of the erythema nodosum. Forty-eight hours after the initiation of therapy the patient developed fever, severe generalized rash, pruritus, and cholestatic and hepatocellular liver function disturbances. Extensive evaluation to determine the cause of liver function disturbances was unrevealing. Marked improvement was noticed within days after cessation of erythromycin.Case reports in the literature on the adverse effects of erythromycin and its derivatives were reviewed. The possible immunologic mechanism involved is postulated.Erythromycin base must be added to the list of erythromycin derivatives that can cause rash and liver function disturbances. The concomitant appearance of fever, rash, jaundice, and liver function disturbances raises the possibility of hypersensitivity as the mechanism for the liver disturbances.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Mebhydrolin napadisylate
CAS:6153-33-9 |
C48H48N4O6S2 |
Three explorative studies on the efficacy of the antihistami...
1995-07-01 [Int. J. Clin. Pharmacol. Ther. 33 , 373, (1995)] |
Metabolic factors and risk of hepatocellular carcinoma by ch...
2008-07-01 [Gastroenterology 135(1) , 111-21, (2008)] |
[Agranulocytosis associated with mebhydrolin napadisylate (I...
1984-03-01 [Harefuah 106(5) , 208-9, (1984)] |
[Effect of antihistaminic preparations on gastric secretion ...
1983-05-01 [Biull. Eksp. Biol. Med. 95(5) , 44-6, (1983)] |
[Methods for detecting diazoline in chemicotoxicological stu...
1991-01-01 [Sud. Med. Ekspert. 34(4) , 46-8, (1991)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved